188 related articles for article (PubMed ID: 30707494)
1. Sonodynamic Therapeutic Effects of Sonosensitizers with Different Intracellular Distribution Delivered by Hollow Nanocapsules Exhibiting Cytosol Specific Release.
Teranishi R; Matsuda T; Yuba E; Kono K; Harada A
Macromol Biosci; 2019 Apr; 19(4):e1800365. PubMed ID: 30707494
[TBL] [Abstract][Full Text] [Related]
2. Doxorubicin Delivery Using pH and Redox Dual-Responsive Hollow Nanocapsules with a Cationic Electrostatic Barrier.
Teranishi R; Matsuki R; Yuba E; Harada A; Kono K
Pharmaceutics; 2016 Dec; 9(1):. PubMed ID: 28042818
[TBL] [Abstract][Full Text] [Related]
3. Redox and pH dual responsive poly(amidoamine) dendrimer-poly(ethylene glycol) conjugates for intracellular delivery of doxorubicin.
Hu W; Qiu L; Cheng L; Hu Q; Liu Y; Hu Z; Chen D; Cheng L
Acta Biomater; 2016 May; 36():241-53. PubMed ID: 26995505
[TBL] [Abstract][Full Text] [Related]
4. Mitochondria-targeting sonosensitizer-loaded extracellular vesicles for chemo-sonodynamic therapy.
Nguyen Cao TG; Truong Hoang Q; Hong EJ; Kang SJ; Kang JH; Ravichandran V; Kang HC; Ko YT; Rhee WJ; Shim MS
J Control Release; 2023 Feb; 354():651-663. PubMed ID: 36682729
[TBL] [Abstract][Full Text] [Related]
5. Poly(PEGA)-b-poly(L-lysine)-b-poly(L-histidine) Hybrid Vesicles for Tumoral pH-Triggered Intracellular Delivery of Doxorubicin Hydrochloride.
Johnson RP; Uthaman S; John JV; Lee HR; Lee SJ; Park H; Park IK; Suh H; Kim I
ACS Appl Mater Interfaces; 2015 Oct; 7(39):21770-9. PubMed ID: 26375278
[TBL] [Abstract][Full Text] [Related]
6. mPEGylated solanesol micelles as redox-responsive nanocarriers with synergistic anticancer effect.
Qin B; Liu L; Wu X; Liang F; Hou T; Pan Y; Song S
Acta Biomater; 2017 Dec; 64():211-222. PubMed ID: 28963017
[TBL] [Abstract][Full Text] [Related]
7. Intracellular environment-responsive stabilization of polymer vesicles formed from head-tail type polycations composed of a polyamidoamine dendron and poly(L-lysine).
Harada A; Matsuki R; Ichimura S; Yuba E; Kono K
Molecules; 2013 Sep; 18(10):12168-79. PubMed ID: 24084020
[TBL] [Abstract][Full Text] [Related]
8. 2,2'-Dithiodisuccinic acid-stabilized polyion complex micelles for pH and reduction dual-responsive drug delivery.
Du Y; Yan W; Lian H; Xiang C; Duan L; Xiao C
J Colloid Interface Sci; 2018 Jul; 522():74-81. PubMed ID: 29579564
[TBL] [Abstract][Full Text] [Related]
9. Doxorubicin delivery by polyamidoamine dendrimer conjugation and photochemical internalization for cancer therapy.
Lai PS; Lou PJ; Peng CL; Pai CL; Yen WN; Huang MY; Young TH; Shieh MJ
J Control Release; 2007 Sep; 122(1):39-46. PubMed ID: 17628166
[TBL] [Abstract][Full Text] [Related]
10. Delivery of mitochondriotropic doxorubicin derivatives using self-assembling hyaluronic acid nanocarriers in doxorubicin-resistant breast cancer.
Liu HN; Guo NN; Guo WW; Huang-Fu MY; Vakili MR; Chen JJ; Xu WH; Wei QC; Han M; Lavasanifar A; Gao JQ
Acta Pharmacol Sin; 2018 Oct; 39(10):1681-1692. PubMed ID: 29849132
[TBL] [Abstract][Full Text] [Related]
11. Drug-loaded titanium dioxide nanoparticle coated with tumor targeting polymer as a sonodynamic chemotherapeutic agent for anti-cancer therapy.
Kim S; Im S; Park EY; Lee J; Kim C; Kim TI; Kim WJ
Nanomedicine; 2020 Feb; 24():102110. PubMed ID: 31666202
[TBL] [Abstract][Full Text] [Related]
12. Stimuli responsive PEGylated bismuth selenide hollow nanocapsules for fluorescence/CT imaging and light-driven multimodal tumor therapy.
Sun L; Li Q; Zhang L; Chai H; Yu L; Xu Z; Kang Y; Xue P
Biomater Sci; 2019 Jul; 7(7):3025-3040. PubMed ID: 31115395
[TBL] [Abstract][Full Text] [Related]
13. Bioreducible Poly(ethylene glycol)-Triphenylphosphonium Conjugate as a Bioactivable Mitochondria-Targeting Nanocarrier.
Khatun Z; Choi YS; Kim YG; Yoon K; Nurunnabi M; Li L; Lee E; Kang HC; Huh KM
Biomacromolecules; 2017 Apr; 18(4):1074-1085. PubMed ID: 28257184
[TBL] [Abstract][Full Text] [Related]
14. Tumor growth inhibition by sonodynamic therapy using a novel sonosensitizer.
Tsuru H; Shibaguchi H; Kuroki M; Yamashita Y; Kuroki M
Free Radic Biol Med; 2012 Aug; 53(3):464-72. PubMed ID: 22588110
[TBL] [Abstract][Full Text] [Related]
15. Combinatory Cancer Therapeutics with Nanoceria-Capped Mesoporous Silica Nanocarriers through pH-triggered Drug Release and Redox Activity.
Singh RK; Patel KD; Mahapatra C; Parthiban SP; Kim TH; Kim HW
ACS Appl Mater Interfaces; 2019 Jan; 11(1):288-299. PubMed ID: 30539634
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of cytotoxicity profile and intracellular localisation of doxorubicin-loaded chitosan nanoparticles.
Souto GD; Farhane Z; Casey A; Efeoglu E; McIntyre J; Byrne HJ
Anal Bioanal Chem; 2016 Aug; 408(20):5443-55. PubMed ID: 27225177
[TBL] [Abstract][Full Text] [Related]
17. A pH-responsive drug nanovehicle constructed by reversible attachment of cholesterol to PEGylated poly(l-lysine) via catechol-boronic acid ester formation.
Yang B; Lv Y; Zhu JY; Han YT; Jia HZ; Chen WH; Feng J; Zhang XZ; Zhuo RX
Acta Biomater; 2014 Aug; 10(8):3686-95. PubMed ID: 24879311
[TBL] [Abstract][Full Text] [Related]
18. Targeted delivery of doxorubicin to mitochondria using mesoporous silica nanoparticle nanocarriers.
Qu Q; Ma X; Zhao Y
Nanoscale; 2015 Oct; 7(40):16677-86. PubMed ID: 26400067
[TBL] [Abstract][Full Text] [Related]
19. Folate-modified poly(2-ethyl-2-oxazoline) as hydrophilic corona in polymeric micelles for enhanced intracellular doxorubicin delivery.
Qiu LY; Yan L; Zhang L; Jin YM; Zhao QH
Int J Pharm; 2013 Nov; 456(2):315-24. PubMed ID: 24016742
[TBL] [Abstract][Full Text] [Related]
20. Alginate-azo/chitosan nanocapsules in vitro drug delivery for hepatic carcinoma cells: UV-stimulated decomposition and drug release based on trans-to-cis isomerization.
Chen Q; Li X; Xie Y; Hu W; Cheng Z; Zhong H; Zhu H
Int J Biol Macromol; 2021 Sep; 187():214-222. PubMed ID: 34314790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
